Increased serum ADAMTS-4 in knee osteoarthritis: A potential indicator for the diagnosis of osteoarthritis in early stages

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 9642-9649

  Li, W ^a   Du, C ^a   Wang, H ^a   Zhang, C ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

ADAMTS; MMP; Osteoarthritis

Indexed keywords

AGGRECANASE 1; AGGRECANASE 2; COLLAGEN; INTERSTITIAL COLLAGENASE; STROMELYSIN; ADAM PROTEIN; AGGRECANASE-1; BIOLOGICAL MARKER; PROCOLLAGEN N PROTEINASE;

ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ONTOLOGY; GENETIC ASSOCIATION; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; EARLY DIAGNOSIS; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; OSTEOARTHRITIS, KNEE; PATHOLOGY; PROTEIN ANALYSIS; SEVERITY OF ILLNESS INDEX;

ADAM PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLLAGEN; DISEASE PROGRESSION; EARLY DIAGNOSIS; GENE EXPRESSION; GENE REGULATORY NETWORKS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; OSTEOARTHRITIS, KNEE; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEIN INTERACTION MAPPING; SEVERITY OF ILLNESS INDEX;

EID: 84924911599     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.November.14.9     Document Type: Article

References (28)

1. Ameye LG and Young MF (2006). Animal models of osteoarthritis: lessons learned while seeking the ‘Holy Grail’. Curr. Opin. Rheumatol. 18: 537-547.
2. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, et al. (2010). Sensitization in patients with painful knee osteoarthritis. Pain 149: 573-581.
3. Behera AK, Hildebrand E, Szafranski J, Hung HH, et al. (2006). Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum. 54: 3319-3329.
4. Bijlsma JW, Berenbaum F and Lafeber FP (2011). Osteoarthritis: an update with relevance for clinical practice. Lancet 377: 2115-2126.
5. Brama PA, van den Boom R, DeGroot J, Kiers GH, et al. (2004). Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis. Equine Vet. J. 36: 34-40.
6. Cheung KS, Hashimoto K, Yamada N and Roach HI (2009). Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol. Int. 29: 525-534.
7. Chia SL, Sawaji Y, Burleigh A, McLean C, et al. (2009). Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60: 2019-2027.
8. Fosang AJ, Rogerson FM, East CJ and Stanton H (2008). ADAMTS-5: the story so far. Eur. Cell Mater. 15: 11-26.
9. Glasson SS, Askew R, Sheppard B, Carito BA, et al. (2004). Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50: 2547-2558.
10. Huang da W, Sherman BT and Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4: 44-57.
11. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, et al. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7: 33-42.
12. Lin PM, Chen CT and Torzilli PA (2004). Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3-and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis Cartilage 12: 485-496.
13. Mahmoud RK, El-Ansary AK, H. El-Eishi HH, Kamal HM, et al. (2005). Matrix metalloproteinases MMP-3 and MMP-1 levels sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital. J. Biochem. 54: 248-257.
14. Majumdar MK, Askew R, Schelling S, Stedman N, et al. (2007). Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum. 56: 3670-3674.
15. Mizui Y, Yamazaki K, Kuboi Y, Sagane K, et al. (2000). Characterization of 5¢-flanking region of human aggrecanase-1 (ADAMTS4) gene. Mol. Biol. Rep. 27: 167-173.
16. Poole AR, Ionescu M, Swan A and Dieppe P (1994). Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J. Clin. Invest. 94: 25-33.
17. Porter S, Clark IM, Kevorkian L and Edwards DR (2005). The ADAMTS metalloproteinases. Biochem. J. 386: 15-27.
18. Ray A, Kuroki K, Cook JL, Bal BS, et al. (2003). Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum. 48: 134-145.
19. Recht MP, Kramer J, Marcelis S, Pathria MN, et al. (1993). Abnormalities of articular cartilage in the knee: analysis of available MR techniques. Radiology 187: 473-478.
20. Song RH, Tortorella MD, Malfait AM, Alston JT, et al. (2007). Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56: 575-585.
21. Takahashi K, Goomer RS, Harwood F, Kubo T, et al. (1999). The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1β (IL-1b), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 7: 182-190.
22. Tchetverikov I, Ronday HK, Van El B, Kiers GH, et al. (2004). MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann. Rheum. Dis. 63: 881-883.
23. Tortorella MD, Arner EC, Hills R, Easton A, et al. (2004). Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J. Biol. Chem. 279: 17554-17561.
24. Verma P and Dalal K (2011). ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis. J. Cell Biochem. 112: 3507-3514.
25. Wei M, Duan D, Liu Y, Wang Z, et al. (2013). Increased thymosin beta4 levels in the serum and SF of knee osteoarthritis patients correlate with disease severity. Regul. Pept. 185: 34-36.
26. Yamanaka H, Matsuda Y, Tanaka M, Sendo W, et al. (2000). Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum. 43: 852-858.
27. Yoshihara Y, Nakamura H, Obata K, Yamada H, et al. (2000). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59: 455-461.
28. Zeggini E, Panoutsopoulou K, arcOGEN Consortium, arcORGEN Collaborators et al. (2012). Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 380: 815-823.